Revision history of "A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease" (Q36467473)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 July 2024

22 January 2024

12 October 2022

7 December 2021

28 October 2021

13 March 2021

14 April 2020

5 January 2020

7 July 2019

28 March 2019

18 February 2019

  • curprev 05:3205:32, 18 February 2019 Emijrpbot talk contribs 44,700 bytes +4,825 Updated Item: BOT - Adding descriptions (57 languages): ast, bg, bn, ca, cs, da, de, el, eo, es, et, fa, fi, fr, gl, he, hu, hy, it, ja, ka, ko, lt, nan, nb, nl, nn, oc, pl, pt, pt-br, ro, ru, sk, sq, sr, sr-ec, sr-el, sv, tg, tg-cyrl, th, tl, tr, ur, vi, wuu, yue, zh, zh-cn, zh-hans, zh-hant, zh-hk, zh-mo, zh-my, zh-sg, zh-tw undo (restore)

11 November 2018

22 August 2018

13 July 2018

28 June 2018

9 April 2018

8 November 2017

23 October 2017

14 August 2017